Since our results suggest that transient knockdown of HDAC2 exerts potent anti-tumor activity, we next investigated if sustained suppression of HDAC2 can attenuate tumorigenic potential of HCC cells in vitro and in vivo. This evidence concerns the gene HDAC2 and hepatocellular carcinoma.